Level Chart

Basic Info

Boston Scientific Corp (BSX) - Cardiovascular Organic Revenue Growth is at 19.40%, compared to 23.20% last quarter and 24.60% last year. This is higher than the long term average of 12.76%.

Region United States
Source Fiscal.ai

Data provided via Fiscal.ai

Stats

Last Value 19.40%
Latest Period Sep 2025
Last Updated Dec 18 2025, 15:07 EST
Next Release Jan 30 2026, 08:30 EST (E)
Long Term Average 12.76%
Average Growth Rate 204.0%
Value from Last Quarter 23.20%
Change from Last Quarter -16.38%
Value from 1 Year Ago 24.60%
Change from 1 Year Ago -21.14%
Frequency Quarterly
Unit Percent
Adjustment N/A
Download Source File Upgrade

Historical Data

View and export this data back to 2019. Upgrade now.
Date Value
September 30, 2025 19.40%
June 30, 2025 23.20%
March 31, 2025 25.60%
December 31, 2024 27.40%
September 30, 2024 24.60%
June 30, 2024 19.00%
March 31, 2024 16.30%
December 31, 2023 13.30%
September 30, 2023 10.60%
June 30, 2023 13.40%
March 31, 2023 14.40%
December 31, 2022 9.40%
Date Value
September 30, 2022 12.60%
June 30, 2022 7.80%
March 31, 2022 10.80%
December 31, 2021 27.00%
September 30, 2021 18.50%
June 30, 2021 47.20%
March 31, 2021 7.40%
December 31, 2020 -13.50%
September 30, 2020 -10.40%
June 30, 2020 -25.30%
March 31, 2020 -2.50%
December 31, 2019 10.00%

Basic Info

Boston Scientific Corp (BSX) - Cardiovascular Organic Revenue Growth is at 19.40%, compared to 23.20% last quarter and 24.60% last year. This is higher than the long term average of 12.76%.

Region United States
Source Fiscal.ai

Data provided via Fiscal.ai

Stats

Last Value 19.40%
Latest Period Sep 2025
Last Updated Dec 18 2025, 15:07 EST
Next Release Jan 30 2026, 08:30 EST (E)
Long Term Average 12.76%
Average Growth Rate 204.0%
Value from Last Quarter 23.20%
Change from Last Quarter -16.38%
Value from 1 Year Ago 24.60%
Change from 1 Year Ago -21.14%
Frequency Quarterly
Unit Percent
Adjustment N/A
Download Source File Upgrade

Related Securities

Symbol Name Change %
BSX Boston Scientific Corp. -0.69%